Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Scandinavian Journal of Pain

Official Journal of the Scandinavian Association for the Study of Pain

Editor-in-Chief: Werner, Mads

CiteScore 2018: 0.85

SCImago Journal Rank (SJR) 2018: 0.494
Source Normalized Impact per Paper (SNIP) 2018: 0.427

See all formats and pricing
More options …
Volume 16, Issue 1


Glucocorticoids – Efficient analgesics against postherpetic neuralgia?

Mette Richner / Christian Bjerggaard Vaegter
Published Online: 2017-07-01 | DOI: https://doi.org/10.1016/j.sjpain.2017.03.003


  • [1]

    Rijsdijk M, Agalave NM, van Wijck AJ, Kalkman CJ, Ramachandran R, Baharpoor A, Svensson CI, Yaksh TL. Effect of intrathecal glucocorticoids on the central glucocorticoid receptor in a rat nerve ligation model. Scand J Pain 2017;16:1–9.CrossrefGoogle Scholar

  • [2]

    Rijsdijk M, van Wijck AJ, Meulenhoff PC, Kavelaars A, van der Tweel I, Kalkman CJ. No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients. Eur J Pain 2013;17:714–23, http://dx.doi.org/10.1002/j.1532-2149.2012.00233.x.CrossrefPubMed

  • [3]

    Kotani N, Kushikata T, Hashimoto H, Kimura F, Muraoka M, Yodono M, Asai M, Matsuki A. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000;343:1514–9, http://dx.doi.org/10.1056/NEJM200011233432102.CrossrefPubMed

  • [4]

    Gardner WJ, Goebert Jr HW, Sehgal AD. Intraspinal corticosteroids in the treatment of sciatica. Trans Am Neurol Assoc 1961;86:214–5.PubMedGoogle Scholar

  • [5]

    Winnie AP, Hartman JT, Meyers Jr HL, Ramamurthy S, Barangan V. Pain clinic. II. Intradural and extradural corticosteroids for sciatica. Anesth Analg 1972;51:990–1003.PubMedGoogle Scholar

  • [6]

    Lu J, Katano T, Nishimura W, Fujiwara S, Miyazaki S, Okasaki I, Aritake K, Urade Y, Minami T, Ito S. Proteomic analysis of cerebrospinal fluid before and after intrathecal injection of steroid into patients with postherpetic pain. Proteomics 2012;12:3105–12, http://dx.doi.org/10.1002/pmic.201200125.CrossrefPubMed

  • [7]

    Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell 2009;138:30–50, http://dx.doi.org/10.1016/j.cell.2009.06.036.PubMedCrossref

  • [8]

    Helmuth IG, Poulsen A, Suppli CH, Molbak K. Varicella in Europe-A review of the epidemiology and experience with vaccination. Vaccine 2015;33:2406–13, http://dx.doi.org/10.1016/j.vaccine.2015.03.055.CrossrefPubMed

  • [9]

    Steiner I, Kennedy PG, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 2007;6:1015–28, http://dx.doi.org/10.1016/S1474-4422(07)70267-3.CrossrefPubMed

  • [10]

    Eshleman E, Shahzad A, Cohrs RJ. Varicella zoster virus latency. Future Virol 2011;6:341–55.PubMedCrossrefGoogle Scholar

  • [11]

    Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, Seward JF, Yamanishi K. Varicella zoster virus infection. Nat Rev Dis Primers 2015;1:15016, http://dx.doi.org/10.1038/nrdp.2015.16.PubMed

  • [12]

    Kennedy PG, Grinfeld E, Gow JW. Latent Varicella-zoster virus in human dorsal root ganglia. Virology 1999;258:451–4, http://dx.doi.org/10.1006/viro.1999.9745.CrossrefPubMed

  • [13]

    Cohrs RJ, Gilden DH. Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia. J Virol 2007;81:2950–6, http://dx.doi.org/10.1128/JVI.02745-06.PubMedCrossref

  • [14]

    Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 2003;188:1336–44, http://dx.doi.org/10.1086/379048.CrossrefPubMed

  • [15]

    Pinchinat S, Cebrian-Cuenca AM, Bricout H, Johnson RW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis 2013;13:170, http://dx.doi.org/10.1186/1471-2334-13-170.PubMedCrossref

  • [16]

    Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clinic Proc 2007;82:1341–9.CrossrefGoogle Scholar

  • [17]

    Klompas M, Kulldorff M, Vilk Y, Bialek SR, Harpaz R. Herpes zoster and postherpetic neuralgia surveillance using structured electronic data. Mayo Clinic Proc 2011;86:1146–53, http://dx.doi.org/10.4065/mcp.2011.0305.Crossref

  • [18]

    Dworkin RH, Gnann Jr JW, Oaklander AL, Raja SN, Schmader KE, Whitley RJ. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain 2008;9:S37–44, http://dx.doi.org/10.1016/j.jpain.2007.10.008.PubMedCrossref

  • [19]

    Levin MJ, Gershon AA, Dworkin RH, Brisson M, Stanberry L. Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol 2010;48(Suppl. 1):S14–9, http://dx.doi.org/10.1016/S1386-6532(10)70004-4.CrossrefPubMed

  • [20]

    Carrillo-Santisteve P, Lopalco PL. Varicella vaccination: a laboured take-off. Clin Microbiol Infect 2014;20(Suppl. 5):86–91, http://dx.doi.org/10.1111/1469-0691.12580.PubMedCrossref

  • [21]

    Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, European Federation of Neurological, S. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:1113–88, http://dx.doi.org/10.1111/j.1468-1331.2010.02999.x.Crossref

  • [22]

    Ellis A, Bennett DL. Neuroinflammation and the generation of neuropathic pain. Br J Anaesth 2013;111:26–37, http://dx.doi.org/10.1093/bja/aet128.PubMedCrossref

  • [23]

    Gowrishankar K, Steain M, Cunningham AL, Rodriguez M, Blumbergs P, Slobedman B, Abendroth A. Characterization of the host immune response in human Ganglia after herpes zoster. J Virol 2010;84:8861–70, http://dx.doi.org/10.1128/JVI.01020-10.PubMedCrossref

  • [24]

    Hench PS, Kendall EC, Slocumb CH, Polley HF. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. In: Proceedings of the Staff Meetings. Mayo Clinic, 24. 1949. p. 181–97.Google Scholar

  • [25]

    Rijsdijk M, van Wijck AJ, Kalkman CJ, Yaksh TL. The effects of glucocorticoids on neuropathic pain: a review with emphasis on intrathecal methylprednisolone acetate delivery. Anesth Analg 2014;118:1097–112, http://dx.doi.org/10.1213/ANE.0000000000000161.PubMedCrossref

  • [26]

    Groeneweg FL, Karst H, de Kloet ER, Joels M. Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol 2011;209:153–67, http://dx.doi.org/10.1530/JOE-10-0472.CrossrefPubMed

  • [27]

    Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax 2000;55:603–13.PubMedCrossrefGoogle Scholar

  • [28]

    Moore FL, Evans SJ. Steroid hormones use non-genomic mechanisms to control brain functions and behaviors: a review of evidence. Brain Behav Evol 1999;54:41–50.PubMedCrossrefGoogle Scholar

  • [29]

    Ji RR, Gereau RWt, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009;60:135–48, http://dx.doi.org/10.1016/j.brainresrev.2008.12.011.PubMedCrossref

  • [30]

    Kalia LV, Gingrich JR, Salter MW. Src in synaptic transmission and plasticity. Oncogene 2004;23:8007–16, http://dx.doi.org/10.1038/sj.onc.1208158.PubMedCrossref

  • [31]

    Gao YJ, Ji RR. Targeting astrocyte signaling for chronic pain. Neurotherapeutics 2010;7:482–93, http://dx.doi.org/10.1016/j.nurt.2010.05.016.PubMedCrossref

  • [32]

    Tsuda M, Masuda T, Tozaki-Saitoh H, Inoue K. Microglial regulation of neuropathic pain. J Pharmacol Sci 2013;121:89–94.PubMedCrossrefGoogle Scholar

  • [33]

    Li JY, Xie W, Strong JA, Guo QL, Zhang JM. Mechanical hypersensitivity, sympathetic sprouting, and glial activation are attenuated by local injection of corticosteroid near the lumbar ganglion in a rat model of neuropathic pain. Reg Anesth Pain Med 2011;36:56–62, http://dx.doi.org/10.1097/AAP.0b013e318203087f.Crossref

  • [34]

    Takeda K, Sawamura S, Sekiyama H, Tamai H, Hanaoka K. Effect of methylprednisolone on neuropathic pain and spinal glial activation in rats. Anesthesiology 2004;100:1249–57.CrossrefPubMedGoogle Scholar

  • [35]

    Wang QS, Jiang YH, Wang TD, Xiao T, Wang JK. Effects of betamethasone on neuropathic pain in a rat spare nerve injury model. Clin Exp Pharmacol Physiol 2013;40:22–7, http://dx.doi.org/10.1111/1440-1681.12027.Crossref

  • [36]

    Scholz J, Abele A, Marian C, Haussler A, Herbert TA, Woolf CJ, Tegeder I. Low-dose methotrexate reduces peripheral nerve injury-evoked spinal microglial activation and neuropathic pain behavior in rats. Pain 2008;138:130–42, http://dx.doi.org/10.1016/j.pain.2007.11.019.PubMedCrossref

  • [37]

    Sehgal AD, Gardner WJ. Place of intrathecal methylprednisolone acetate in neurological disorders. Trans Am Neurol Assoc 1963;88:275–6.PubMedGoogle Scholar

  • [38]

    Abu-Mugheisib M, Benecke R, Zettl UK. Management of spasticity in progressive multiple sclerosis: efficacy of repeated intrathecal triamcinolone acetonide administration. Curr Pharm Des 2012;18:4564–9.CrossrefPubMedGoogle Scholar

  • [39]

    Nelson DA, Landau WM. Intraspinal steroids: history, efficacy, accidentality, and controversy with review of United States Food and Drug Administration reports. J Neurol Neurosurg Psychiatry 2001;70:433–43.PubMedCrossrefGoogle Scholar

  • [40]

    Bani-Hashem N, Hassan-Nasab B, Pour EA, Maleh PA, Nabavi A, Jabbari A. Addition of intrathecal Dexamethasone to Bupivacaine for spinal anesthesia in orthopedic surgery. Saudi J Anaesth 2011;5:382–6, http://dx.doi.org/10.4103/1658-354X.87267.CrossrefPubMed

  • [41]

    Sehgal AD, Gardner WJ. Corticosteroids administered intradurally for relief of sciatica. Clevel Clinic Q 1960;27:198–201.CrossrefGoogle Scholar

  • [42]

    Sehgal AD, Tweed DC, Gardner WJ, Foote MK. Laboratory studies after intrathecal corticosteroids: determination of corticosteroids in plasma and cerebrospinal fluid. Arch Neurol 1963;9:64–8.PubMedCrossrefGoogle Scholar

  • [43]

    Shahzad A, Gilden D, Cohrs RJ. Translational medicine and varicella zoster virus: need for disease modeling. New Horiz Transl Med 2015;2:89–91, http://dx.doi.org/10.1016/j.nhtm.2015.03.001.PubMed

  • [44]

    Hasnie FS, Breuer J, Parker S, Wallace V, Blackbeard J, Lever I, Kinchington PR, Dickenson AH, Pheby T, Rice AS. Further characterization of a rat model of varicella zoster virus-associated pain: relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience 2007;144:1495–508, http://dx.doi.org/10.1016/j.neuroscience.2006.11.029.PubMedCrossref

  • [45]

    Rijsdijk MSC, van Wijck AJ, Kalkman CJ, Yaksh TL. Analgesic properties of intrathecal glucocorticoids in three well established preclinical pain models. Scand J Pain 2016;10:90–102.PubMedGoogle Scholar

  • [46]

    Peng J, Gu N, Zhou L, U BE, Murugan M, Gan WB, Wu LJ. Microglia and monocytes synergistically promote the transition from acute to chronic pain after nerve injury. Nat Commun 2016;7:12029, http://dx.doi.org/10.1038/ncomms12029.PubMedCrossref

  • [47]

    Greenspan JD, Craft RM, LeResche L, Arendt-Nielsen L, Berkley KJ, Fillingim RB, Gold MS, Holdcroft A, Lautenbacher S, Mayer EA, Mogil JS, Murphy AZ, Traub RJ, Consensus Working Group of the Sex, G. & Pain, S.I. G. o. t. I. Studying sex and gender differences in pain and analgesia: a consensus report. Pain 2007;132(Suppl. 1):S26–45, http://dx.doi.org/10.1016/j.pain.2007.10.014.Crossref

  • [48]

    Manson JE. Pain: sex differences and implications for treatment. Metab: Clin Exp 2010;59(Suppl. 1):S16–20, http://dx.doi.org/10.1016/j.metabol.2010.07.013.CrossrefPubMed

  • [49]

    Sorge RE, Mapplebeck JC, Rosen S, Beggs S, Taves S, Alexander JK, Martin LJ, Austin JS, Sotocinal SG, Chen D, Yang M, Shi XQ, Huang H, Pillon NJ, Bilan PJ, Tu Y, Klip A, Ji RR, Zhang J, Salter MW, Mogil JS. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat Neurosci 2015;18:1081–3, http://dx.doi.org/10.1038/nn.4053.CrossrefPubMed

  • [50]

    Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Mansfield K, Minassian C, Langan SM. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: a cohort study. Neurology 2016;87:94–102, http://dx.doi.org/10.1212/WNL.0000000000002808.PubMedCrossref

  • [51]

    Haslam C, Nurmikko T. Pharmacological treatment of neuropathic pain in older persons. Clin Interv Aging 2008;3:111–20.CrossrefPubMedGoogle Scholar

About the article

Department of Biomedicine, Aarhus University, Ole Worms Allé 3, Aarhus DK-8000, Denmark.

Published Online: 2017-07-01

Published in Print: 2017-07-01

Conflict of interest: None declared.

Citation Information: Scandinavian Journal of Pain, Volume 16, Issue 1, Pages 61–63, ISSN (Online) 1877-8879, ISSN (Print) 1877-8860, DOI: https://doi.org/10.1016/j.sjpain.2017.03.003.

Export Citation

© 2017 Scandinavian Association for the Study of Pain.Get Permission

Comments (0)

Please log in or register to comment.
Log in